| |
DUR-928, an endogenous regulatory molecule, exhibits
anti-inflammatory and antifibrotic activity in a mouse model of NASH
|
| |
| |
Reported by Jules Levin
AASLD's Emerging Trends in NAFLD, Washington DC, March 17-18, 2017
Mee J. Kim, WeiQi Lin, DURECT Corporation, Cupertino, CA, USA
|
|
| |
| |
|
|
|
